Integer Holdings Corporation $ITGR Shares Sold by Laurus Global Equity Management Inc.

Laurus Global Equity Management Inc. lessened its holdings in Integer Holdings Corporation (NYSE:ITGR) by 77.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,860 shares of the medical equipment provider’s stock after selling 52,040 shares during the quarter. Integer comprises approximately 0.9% of Laurus Global Equity Management Inc.’s investment portfolio, making the stock its 24th largest holding. Laurus Global Equity Management Inc.’s holdings in Integer were worth $1,165,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Salomon & Ludwin LLC increased its holdings in Integer by 46.8% in the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 118 shares during the period. Orion Porfolio Solutions LLC boosted its position in Integer by 1.4% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock worth $1,200,000 after purchasing an additional 138 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in Integer by 9.2% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 1,979 shares of the medical equipment provider’s stock worth $205,000 after purchasing an additional 166 shares in the last quarter. Azzad Asset Management Inc. ADV boosted its position in Integer by 1.1% in the 4th quarter. Azzad Asset Management Inc. ADV now owns 14,833 shares of the medical equipment provider’s stock worth $1,163,000 after purchasing an additional 167 shares in the last quarter. Finally, Osaic Holdings Inc. boosted its position in Integer by 8.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,543 shares of the medical equipment provider’s stock worth $312,000 after purchasing an additional 188 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Price Performance

Shares of NYSE:ITGR traded down $1.49 during midday trading on Thursday, reaching $83.67. 210,597 shares of the company’s stock traded hands, compared to its average volume of 721,568. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $127.56. The company has a market cap of $2.85 billion, a P/E ratio of 29.40, a PEG ratio of 1.45 and a beta of 0.71. The company has a debt-to-equity ratio of 0.69, a quick ratio of 2.23 and a current ratio of 3.32. The company has a fifty day simple moving average of $86.07 and a two-hundred day simple moving average of $82.37.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, February 19th. The medical equipment provider reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.06. Integer had a return on equity of 13.26% and a net margin of 5.55%.The firm had revenue of $472.06 million for the quarter, compared to analyst estimates of $462.73 million. During the same quarter last year, the firm posted $1.43 EPS. The business’s revenue was up 5.0% on a year-over-year basis. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. Equities analysts predict that Integer Holdings Corporation will post 6.47 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have commented on ITGR shares. Wells Fargo & Company upped their price objective on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, February 20th. Truist Financial upped their price objective on Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Wall Street Zen lowered Integer from a “buy” rating to a “hold” rating in a research report on Sunday, January 25th. Raymond James Financial restated an “outperform” rating and issued a $101.00 price objective on shares of Integer in a research report on Monday, February 23rd. Finally, Citigroup upped their price objective on Integer from $75.00 to $92.00 and gave the stock a “neutral” rating in a research report on Friday, February 20th. Four research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $102.00.

Insiders Place Their Bets

In other Integer news, VP Tommy P. Thomas sold 825 shares of the firm’s stock in a transaction on Friday, March 13th. The stock was sold at an average price of $85.00, for a total value of $70,125.00. Following the transaction, the vice president owned 4,381 shares in the company, valued at approximately $372,385. This trade represents a 15.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 2.16% of the company’s stock.

Integer Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.